Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer
NCT01781403
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Rectal Cancer
Interventions
DRUG:
Temozolomide
Sponsor
Asan Medical Center